Tigermed Consulting kicks off Hong Kong secondary listing
Shenzhen-listed Hangzhou Tigermed Consulting has caught the attention of international and local investors for its secondary listing on the Hong Kong exchange, set to be worth at least $1bn.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: